Fmc (FMC) Stock News

FMC Corporation (NYSE: FMC) announced that three of its top executives will present at the upcoming Jefferies Industrials Conference. Chairman and CEO Pierre Brondeau, President Ronaldo Pereira, and Executive VP and CFO Andrew Sandifer will speak on September 3, 2025, at 7:30 a.m. ET. Investors can access the live webcast through the company's investor relations website at www.fmc.com/investors.

FMC Corporation (NYSE: FMC) has secured registration for Fundatis® herbicide in Great Britain for winter wheat and winter barley applications. The herbicide, powered by Isoflex® active, is classified as a Group 13 herbicide by HRAC and combines two previously unavailable active ingredients in Great Britain.

Fundatis® herbicide effectively controls key annual grass weeds like Blackgrass and Italian Ryegrass, along with broadleaf weeds such as Groundsel and Speedwell. The product will be available during the fall growing season in Great Britain. Isoflex® active has already been registered in several countries including Argentina, Australia, Brazil, and China, with a pending application in the European Union.

FMC Corporation (NYSE:FMC) reported Q2 2025 results with revenue of $1.05 billion, up 1% year-over-year and 2% organically. The company posted adjusted EBITDA of $207 million (up 2%) and adjusted EPS of $0.69 (up 10%). Notably, FMC announced plans to divest its India commercial business while maintaining manufacturing operations there.

The company maintained its full-year 2025 guidance with adjusted EBITDA of $870-950 million and adjusted EPS of $3.26-3.70. Revenue outlook excluding India is set at $4.08-4.28 billion, down 2% at midpoint versus 2024. Free cash flow forecast remains at $200-400 million, reflecting a 51% decline at midpoint from prior year.

Regional performance varied with EMEA showing strong growth (+29%), while Asia declined (-17%) and North America decreased (-5%). The company's growth portfolio increased by high-single digits.

FMC Corporation (NYSE: FMC) has announced its board of directors has declared a regular quarterly dividend of $0.58 per share. The dividend will be paid on October 16, 2025, to shareholders of record at the close of business on September 30, 2025.

FMC Corporation (NYSE: FMC) has received regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of its fluindapyr technology in the EMEA region. The approval covers applications for oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.

Tremisia® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, providing a dual mode of action that targets diseases including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. The product has already been successfully commercialized in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval in the Philippines.

The company plans to expand the availability of fluindapyr-based products to Bolivia, Chile, Colombia, Honduras, and India, pending regulatory approvals.

FMC Corporation has scheduled its second quarter 2025 earnings release for Wednesday, July 30, 2025, after market close. The company will host a webcast conference call the following day, Thursday, July 31, 2025, at 9:00 a.m. ET. The call will be accessible to the public via internet broadcast and telephone, with both U.S. local and toll-free numbers provided. A replay of the call will be available from 11:00 a.m. ET on July 31 until August 7, 2025, through both internet and telephone access.

FMC Corporation has announced a strategic partnership with Corteva Agriscience to expand the reach of its fluindapyr fungicide technology in U.S. corn and soybean markets. The agreement allows both companies to market fluindapyr-based products, with FMC continuing to offer Adastrio fungicide while developing new products, and Corteva launching its own fluindapyr-based product in early 2026, pending EPA approval. The collaboration targets approximately 175 million planted acres across corn and soybean markets, offering farmers enhanced protection against diseases like tar spot and southern rust. Fluindapyr, a Group 7 fungicide, provides extended residual control and effectively manages pathogen resistance. FMC has already commercialized fluindapyr products in several countries including Argentina, Brazil, and South Korea, with planned launches in Chile, Honduras, India, and Ukraine pending regulatory approval.

FMC Corporation (NYSE: FMC) has released its 2024 sustainability report, showcasing significant progress in environmental initiatives and agricultural innovation. The company achieved a 27% reduction in Scope 1 and 2 greenhouse gas emissions from its 2021 baseline through energy efficiency projects and clean energy procurement. Additionally, waste reduction initiatives led to a 6% decrease in waste generation, with both environmental efforts contributing to $6 million in operating cost savings.

The report highlights FMC's R&D pipeline developments, including new fungicides, pheromone-based products, microbial solutions, and diamide formulations. The company's integrated approach focuses on helping farmers improve productivity while promoting sustainable agricultural practices such as reduced water usage, enhanced soil quality, and pollinator protection.

FMC Corporation reported Q1 2025 results with revenue of $791 million, down 14% from Q1 2024. The company posted a GAAP loss of $0.12 per share and adjusted earnings of $0.18 per share, down 50% year-over-year.

Despite Q1 challenges, FMC maintains its full-year 2025 outlook with:

• Revenue forecast: $4.15-4.35 billion
• Adjusted EBITDA: $870-950 million
• Adjusted EPS: $3.26-3.70

Regional performance varied significantly: North America sales declined 28%, Latin America grew 10%, Asia dropped 24%, and EMEA fell 11%. The company expects stronger second-half performance with a projected 7% increase in sales and 11% growth in adjusted EBITDA compared to 2024.